REMEDY BIOLOGICS LIMITED

Remedy BioLogics Limited is a Dublin‑based nano‑scale biotechnology company at the forefront of ultra‑high‑throughput therapeutic discovery. By decoding immune biology and mapping the function of cells directly from patient samples, the firm harnesses the power of the human immune system to develop new treatments for the world’s most challenging diseases.

The company’s core specialisation lies in rapid, data‑driven identification of therapeutic candidates, leveraging cutting‑edge genomics, big‑data analytics and artificial intelligence to translate patient‑derived biology into viable drug programmes. This approach enables Remedy BioLogics to serve pharmaceutical partners, academic research centres and clinical innovators seeking novel, immune‑focused therapies.

Backed by a leadership team with deep experience in genomics, AI, and translational medicine, Remedy BioLogics combines scientific rigour with entrepreneurial agility, positioning itself as a catalyst for breakthrough medicines that move swiftly from discovery to patient benefit.